{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T21:02:18Z","timestamp":1762808538873,"version":"3.44.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R21EB016792"],"award-info":[{"award-number":["R21EB016792"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA175318"],"award-info":[{"award-number":["R01CA175318"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shared Resources of the Rutgers Cancer Institute of New Jersey","award":["P30CA072720"],"award-info":[{"award-number":["P30CA072720"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.biomaterials.2017.10.028","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T05:45:12Z","timestamp":1508478312000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Bioengineering a non-genotoxic vector for genetic modification of mesenchymal stem cells"],"prefix":"10.1016","volume":"152","author":[{"given":"Xuguang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Nomani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niket","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faranak S.","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Hatefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biomaterials.2017.10.028_bib1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.addr.2011.06.010","article-title":"Mesenchymal stem cells engineered for cancer therapy","volume":"64","author":"Shah","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.biomaterials.2017.10.028_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1349-7006.2005.00032.x","article-title":"Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy","volume":"96","author":"Hamada","year":"2005","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.10.028_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbrc.2004.12.164","article-title":"Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas","volume":"328","author":"Uhl","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"13","key":"10.1016\/j.biomaterials.2017.10.028_bib4","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1158\/0008-5472.CAN-06-4024","article-title":"Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy","volume":"67","author":"Kucerova","year":"2007","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.10.028_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/mt.2009.237","article-title":"Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth","volume":"18","author":"Cavarretta","year":"2010","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.biomaterials.2017.10.028_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/cgt.2012.8","article-title":"Induced transgene expression for the treatment of solid tumors by hematopoietic stem cell-based gene therapy","volume":"19","author":"Noyan","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biomaterials.2017.10.028_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2015.01.003","article-title":"Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme\/prodrug systems","volume":"200","author":"Nouri","year":"2015","journal-title":"J.\u00a0Control Release"},{"issue":"10","key":"10.1016\/j.biomaterials.2017.10.028_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/gt.2008.41","article-title":"Stem and progenitor cell-mediated tumor selective gene therapy","volume":"15","author":"Aboody","year":"2008","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.biomaterials.2017.10.028_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"issue":"9","key":"10.1016\/j.biomaterials.2017.10.028_bib10","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.bios.2007.12.009","article-title":"A\u00a0novel electroporation method using a capillary and wire-type electrode","volume":"23","author":"Kim","year":"2008","journal-title":"Biosens. Bioelectron."},{"issue":"2","key":"10.1016\/j.biomaterials.2017.10.028_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0192623310390705","article-title":"Nanotoxicology\u2013a pathologist's perspective","volume":"39","author":"Hubbs","year":"2011","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.10.028_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1166\/jbn.2011.1179","article-title":"Nano-specific genotoxic effects","volume":"7","author":"Norppa","year":"2011","journal-title":"J.\u00a0Biomed. Nanotechnol."},{"issue":"3","key":"10.1016\/j.biomaterials.2017.10.028_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2009.04.017","article-title":"Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells","volume":"138","author":"Canine","year":"2009","journal-title":"J.\u00a0Control Release"},{"issue":"4","key":"10.1016\/j.biomaterials.2017.10.028_bib14","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1021\/mp800251x","article-title":"Development of a genetically engineered biomimetic vector for targeted gene transfer to breast cancer cells","volume":"6","author":"Mangipudi","year":"2009","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.10.028_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2009.03.005","article-title":"A\u00a0designer biomimetic vector with a chimeric architecture for targeted gene transfer","volume":"137","author":"Wang","year":"2009","journal-title":"J.\u00a0Control Release"},{"issue":"12","key":"10.1016\/j.biomaterials.2017.10.028_bib16","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/psc.810","article-title":"Interactions of amphipathic carrier peptides with membrane components in relation with their ability to deliver therapeutics","volume":"12","author":"Deshayes","year":"2006","journal-title":"J.\u00a0Pept. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2017.10.028_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbamem.2004.09.010","article-title":"On the mechanism of non-endosomial peptide-mediated cellular delivery of nucleic acids","volume":"1667","author":"Deshayes","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.biomaterials.2017.10.028_bib18","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1742-4658.2008.06291.x","article-title":"Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult","volume":"275","author":"An","year":"2008","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.biomaterials.2017.10.028_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/psc.2396","article-title":"The agony of choice: how to find a suitable CPP for cargo delivery","volume":"18","author":"Muller","year":"2012","journal-title":"J.\u00a0Pept. Sci."},{"issue":"15\u201316","key":"10.1016\/j.biomaterials.2017.10.028_bib20","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.drudis.2012.03.002","article-title":"Cell-penetrating peptides: classes, origin, and current landscape","volume":"17","author":"Milletti","year":"2012","journal-title":"Drug Discov. Today"},{"issue":"16","key":"10.1016\/j.biomaterials.2017.10.028_bib21","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/smll.201300077","article-title":"Systematic engineering of uniform, highly efficient, targeted and shielded viral-mimetic nanoparticles","volume":"9","author":"Karjoo","year":"2013","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.biomaterials.2017.10.028_bib22","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1021\/bm400380s","article-title":"A\u00a0recombinant biopolymeric platform for reliable evaluation of the activity of pH-responsive amphiphile fusogenic peptides","volume":"14","author":"Nouri","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2017.10.028_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pep.2017.03.012","article-title":"Production of low-expressing recombinant cationic biopolymers with high purity","volume":"134","author":"Chen","year":"2017","journal-title":"Protein Expr. Purif."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2017.10.028_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mrgentox.2007.03.002","article-title":"In\u00a0vitro micronucleus assay scored by flow cytometry provides a comprehensive evaluation of cytogenetic damage and cytotoxicity","volume":"630","author":"Bryce","year":"2007","journal-title":"Mutat. Res."},{"issue":"10","key":"10.1016\/j.biomaterials.2017.10.028_bib25","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1089\/hum.1997.8.10-1253","article-title":"Gene transfer using a novel fusion protein, GAL4\/invasin","volume":"8","author":"Paul","year":"1997","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.biomaterials.2017.10.028_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1517\/17425240903579989","article-title":"Advances with the use of bio-inspired vectors towards creation of artificial viruses","volume":"7","author":"McCarthy","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.10.028_bib27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2010.12.011","article-title":"Development of targeted recombinant polymers that can deliver siRNA to the cytoplasm and plasmid DNA to the cell nucleus","volume":"151","author":"Canine","year":"2011","journal-title":"J.\u00a0Control Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2017.10.028_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nano.2010.08.003","article-title":"HSV-TK\/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector","volume":"7","author":"Wang","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2017.10.028_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2009.03.005","article-title":"A\u00a0designer biomimetic vector with a chimeric architecture for targeted gene transfer","volume":"137","author":"Wang","year":"2009","journal-title":"J.\u00a0Control Release"},{"issue":"11","key":"10.1016\/j.biomaterials.2017.10.028_bib30","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1073\/pnas.102168299","article-title":"Structure and function correlation in histone H2A peptide-mediated gene transfer","volume":"99","author":"Balicki","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"40","key":"10.1016\/j.biomaterials.2017.10.028_bib31","doi-asserted-by":"crossref","first-page":"14215","DOI":"10.1073\/pnas.0505047102","article-title":"Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide","volume":"102","author":"D'Andrea","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"47","key":"10.1016\/j.biomaterials.2017.10.028_bib32","doi-asserted-by":"crossref","first-page":"46681","DOI":"10.1074\/jbc.M308681200","article-title":"A\u00a0vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library","volume":"278","author":"El-Mousawi","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.10.028_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER Suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"},{"issue":"9","key":"10.1016\/j.biomaterials.2017.10.028_bib34","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.bbagen.2006.03.027","article-title":"Structural analysis and classification of native proteins from E. coli commonly co-purified by immobilised metal affinity chromatography","volume":"1760","author":"Bolanos-Garcia","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.biomaterials.2017.10.028_bib35","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1007\/s11095-015-1683-5","article-title":"Reducing the visibility of the vector\/DNA nanocomplexes to the immune system by elastin-like peptides","volume":"32","author":"Nouri","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2017.10.028_bib36","first-page":"8","article-title":"Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids","volume":"10","author":"Shah","year":"2013","journal-title":"Curr. Drug. Discov. Technol."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.10.028_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bjc.6601029","article-title":"Carboxymethyl benzylamide dextran inhibits angiogenesis and growth of VEGF-overexpressing human epidermoid carcinoma xenograft in nude mice","volume":"89","author":"Hamma-Kourbali","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.biomaterials.2017.10.028_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099198","article-title":"Metabolic impact of anti-angiogenic agents on U87 glioma cells","volume":"9","author":"Mesti","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biomaterials.2017.10.028_bib39","first-page":"398","article-title":"Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment","volume":"48","author":"Lim","year":"2007","journal-title":"J.\u00a0Nucl. Med."},{"issue":"6","key":"10.1016\/j.biomaterials.2017.10.028_bib40","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.addr.2009.03.005","article-title":"In\u00a0vitro assessments of nanomaterial toxicity","volume":"61","author":"Jones","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2017.10.028_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/B978-0-12-800148-6.00012-2","article-title":"Polycation-mediated integrated cell death processes","volume":"88","author":"Parhamifar","year":"2014","journal-title":"Adv. Genet."},{"issue":"6","key":"10.1016\/j.biomaterials.2017.10.028_bib42","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ymthe.2005.02.010","article-title":"A\u00a0two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer\/therapy","volume":"11","author":"Moghimi","year":"2005","journal-title":"Mol. Ther."},{"issue":"14","key":"10.1016\/j.biomaterials.2017.10.028_bib43","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.addr.2006.09.008","article-title":"Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity","volume":"58","author":"Hunter","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2017.10.028_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/17435390.2010.485704","article-title":"Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines","volume":"4","author":"Warheit","year":"2010","journal-title":"Nanotoxicology"},{"issue":"7","key":"10.1016\/j.biomaterials.2017.10.028_bib45","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/stem.1388","article-title":"IFN-gamma and TNF-alpha synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFkappaB signaling","volume":"31","author":"Wang","year":"2013","journal-title":"Stem Cells"},{"issue":"4","key":"10.1016\/j.biomaterials.2017.10.028_bib46","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.V90.4.1345","article-title":"Stem cell factor and hematopoiesis","volume":"90","author":"Broudy","year":"1997","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.biomaterials.2017.10.028_bib47","doi-asserted-by":"crossref","first-page":"18600","DOI":"10.1074\/jbc.M311643200","article-title":"Stem cell factor\/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells","volume":"279","author":"Matsui","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"issue":"6","key":"10.1016\/j.biomaterials.2017.10.028_bib48","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1158\/1535-7163.MCT-05-0503","article-title":"Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1alpha activity and vascular endothelial growth factor expression in small cell lung cancer cells","volume":"5","author":"Litz","year":"2006","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2017.10.028_bib49","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1038\/oncsis.2016.88","article-title":"The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells","volume":"6","author":"Redmer","year":"2017","journal-title":"Oncogenesis"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217306816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217306816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:29:39Z","timestamp":1758904179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961217306816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":49,"alternative-id":["S0142961217306816"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.10.028","relation":{},"ISSN":["0142-9612"],"issn-type":[{"type":"print","value":"0142-9612"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioengineering a non-genotoxic vector for genetic modification of mesenchymal stem cells","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}